Inspire Pharmaceuticals in $115 Million Public Offering of Common Stock

August 10, 2009

Cleary Gottlieb represented Deutsche Bank Securities Inc. as sole underwriter in the registered public offering by Inspire Pharmaceuticals, Inc. of 25,555,555 shares of its common stock (including 3,333,332 shares sold pursuant to the underwriter’s exercise in full of its over-allotment option). The offering closed on August 10.

Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases.